Yahu A. Liu

Yahu A. Liu

Auto-generated profile, based on publicly available information

Yahu A. Liu

Kura Oncology, Inc., San Diego, California

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2000 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
LSLawrence M. Sayre
Lawrence M. Sayre
George PerryGeorge Perry
George Perry
PHPeggy L. R. Harris
Peggy L. R. Harris
YLYahua Liu
Yahua Liu
KSKathryn A. Schubert
Kathryn A. Schubert
MSMark A. Smith
Mark A. Smith
There is a great deal of evidence to support a pathogenic role of oxidative stress in Alzheimer’s disease (AD), but the sources of reactive oxygen species have not been directly demonstrated. In this study, using a novel in situ detection system, we show that neurofibrillary tangles and senile plaques are major sites for catalytic redox reactivity. Pretreatment with deferoxamine or diethylenetriaminepentaacetic acid abolishes the ability of the lesions to catalyze the H2O2‐dependent oxidation of 3,3′‐diaminobenzidine (DAB), strongly suggesting the involvement of associated transition metal ions. Indeed, following chelated removal of metals, incubation with iron or copper salts reestablished lesion‐dependent catalytic redox reactivity. Although DAB oxidation can also detect peroxidase activity, this was inactivated by H2O2 pretreatment before use of DAB, as shown by a specific peroxidase detection method. Model studies confirmed the ability of certain copper and iron coordination complexes to catalyze the H2O2‐dependent oxidation of DAB. Also, the microtubule‐associated protein τ, as an in vitro model for proteins relevant to AD pathology, was found capable of adventitious binding of copper and iron in a redox‐competent manner. Our findings suggest that neurofibrillary tangles and senile plaques contain redox‐active transition metals and may thereby exert prooxidant or possibly antioxidant activities, depending on the balance among cellular reductants and oxidants in the local microenvironment.

7 December 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
WLWenqian Li
Wenqian Li
XHXiaofeng Huang
Xiaofeng Huang
TZTengwu Zeng
Tengwu Zeng
YLYahu A. Liu
Yahu A. Liu
WHWeibo Hu
Weibo Hu
WKWen Ke
Wen Ke

26 October 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
WSWeijun Shen
Weijun Shen
BTBrandon Taylor
Brandon Taylor
QJQihui Jin
Qihui Jin
VNVan Nguyen-Tran
Van Nguyen-Tran
SMShelly Meeusen
Shelly Meeusen
BLBryan Laffitte
Bryan Laffitte
Insufficient pancreatic β-cell mass or function results in diabetes mellitus. While significant progress has been made in regulating insulin secretion from β-cells in diabetic patients, no pharmacological agents have been described that increase β-cell replication in humans. Here we report aminopyrazine compounds that stimulate robust β-cell proliferation in adult primary islets, most likely as a result of combined inhibition of DYRK1A and GSK3B. Aminopyrazine-treated human islets retain functionality in vitro and after transplantation into diabetic mice. Oral dosing of these compounds in diabetic mice induces β-cell proliferation, increases β-cell mass and insulin content, and improves glycaemic control. Biochemical, genetic and cell biology data point to Dyrk1a as the key molecular target. This study supports the feasibility of treating diabetes with an oral therapy to restore β-cell mass, and highlights a tractable pathway for future drug discovery efforts.

18 March 2003 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YLYahua Liu
Yahua Liu
WMWilliam W. McWhorter
William W. McWhorter

20 December 2019 in ACS Catalysis
Verified
Journal Article
Closed access
HCHui Chen
Hui Chen
SSShuhao Sun
Shuhao Sun
YLYahu A. Liu
Yahu A. Liu
XLXuebin Liao
Xuebin Liao

20 February 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YLYahu A. Liu
Yahu A. Liu
QJQihui Jin
Qihui Jin
YZYefen Zou
Yefen Zou
QDQiang Ding
Qiang Ding
SYShanshan Yan
Shanshan Yan
JLJon Loren
Jon Loren